From Name

From Email

To Name

To Email

Message

Despite treatment advances, 'much to improve upon' in high-risk neuroblastoma

from HemOnc Today via Healio

Despite treatment advances, 'much to improve upon' in high-risk neuroblastoma HemOnc Today via Healio An estimated 800 new cases of neuroblastoma are diagnosed in the United States each year. Although rare, it is the third most common cancer among children — behind only leukemia and brain/spinal cord tumors — and accounts for 6% of pediatric malignancies. It is by far the most common malignancy among infants. As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD. READ MORE

more